EPTRI and RESTORE Survey on paediatric Advanced Therapies Medicinal Products (ATMP) expertise

Innovative techniques in the biomedical field (such as massive sequencing capacitygene editing and tissue engineering) have resulted in the development of new unconventional drugs in the Advanced Therapy Medicinal Products (ATMPs) class.

In this scenario, the European Paediatric Translational Research Infrastructure (EPTRI) and the EU-funded RESTORE project are collaborating to describe the map of competences available in the framework of the paediatric ATMP research in pan-European countries in order to have the chance to promote the development of tailored paediatric advanced drugs and facilitate collaborations.

To this aim, a survey has been developed and it is available at this link.

The survey is addressed to professionals involved in the development of ATMPs and it takes around 20 minutes to complete.